BIT 3.85% 2.7¢ biotron limited

Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-116

  1. 3,137 Posts.
    lightbulb Created with Sketch. 349
    Below is the Biotron’s pre-IND briefing package referred to in recent ANN

    Small Business and Industry Assistance: Frequently Asked Questions on the Pre-Investigational New Drug (IND) Meeting | FDA

    and then............the next step......................will be.........

    Investigational New Drug (IND) Application | FDA

    Sorry guys seems we are at the very first stage guys

    COVID-19: Developing Drugs and Biological Products for Treatment or Prevention (fda.gov)

    my sentiment is sell because IMO this will go down to 5's again
    dyor
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $24.36M
Open High Low Value Volume
2.6¢ 2.7¢ 2.6¢ $438 16.73K

Buyers (Bids)

No. Vol. Price($)
3 125551 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 157830 2
View Market Depth
Last trade - 12.25pm 15/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.